-
1 Comment
Singapore O&G Ltd is currently in a long term uptrend where the price is trading 6.1% above its 200 day moving average.
From a valuation standpoint, the stock is 61.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.3.
Singapore O&G Ltd's total revenue rose by 105.9% to $22M since the same quarter in the previous year.
Its net income has increased by 164.2% to $6M since the same quarter in the previous year.
Finally, its free cash flow grew by 17.3% to $4M since the same quarter in the previous year.
Based on the above factors, Singapore O&G Ltd gets an overall score of 5/5.
| Exchange | SG |
|---|---|
| CurrencyCode | SGD |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| ISIN | SG1DG2000005 |
| Dividend Yield | 5.5% |
|---|---|
| Beta | 0.88 |
| PE Ratio | 15.56 |
| Target Price | 0.42 |
| Market Cap | 134M |
Singapore O&G Ltd., an investment holding company, provides specialist medical and surgical services for women and children in Singapore. The company operates through four segments: Obstetrics and Gynaecology, Cancer-Related, Dermatology, and Paediatrics. It offers general obstetrics, labor, and delivery; medical problems in pregnancy; and obstetrical complications and its management. The company also provides general gynaecology, gynaecological surgery, female pelvic medicine, urogynaecolog, and reconstructive surgery services; osteoporosis, calcium disorders, pituitary, and adrenal diseases; and reproductive endocrinology, as well as cancer-related services for gynae-oncological, colorectal, breast, thyroid, and general surgery; and diagnostic and therapeutic endoscopic procedures. In addition, it offers dermatology services comprising aesthetics and dermatological procedures, dermatological and laser surgeries, and general skin care services; and paediatrics services, such as newborn and well-baby checks, childhood immunization routine and vaccinations, acute paediatric infections, common childhood conditions, respiratory and behavioral sleep conditions, and gastrointestinal conditions and endoscopic procedures, as well as child nutrition, growth, and developmental assessment. As of December 31, 2021, the company operated through a network of 17 clinics. Singapore O&G Ltd. was incorporated in 2011 and is based in Singapore. As of May 4, 2022, Singapore O&G Ltd. operates as a subsidiary of Hanaan Health Group Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1D8.SG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
